These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23641775)
1. Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study. Weber MF; Cunich M; Smith DP; Salkeld G; Sitas F; O'Connell D BMC Public Health; 2013 May; 13():429. PubMed ID: 23641775 [TBL] [Abstract][Full Text] [Related]
2. Cancer Screening among immigrants living in urban and regional Australia: results from the 45 and up study. Weber MF; Chiew M; Feletto E; Kahn C; Sitas F; Webster L Int J Environ Res Public Health; 2014 Aug; 11(8):8251-66. PubMed ID: 25153460 [TBL] [Abstract][Full Text] [Related]
3. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. Weber MF; Banks E; Ward R; Sitas F J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096 [TBL] [Abstract][Full Text] [Related]
4. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain. Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710 [TBL] [Abstract][Full Text] [Related]
5. Cancer screening among Latino subgroups in the United States. Gorin SS; Heck JE Prev Med; 2005 May; 40(5):515-26. PubMed ID: 15749133 [TBL] [Abstract][Full Text] [Related]
6. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. McCarthy AM; Kim JJ; Beaber EF; Zheng Y; Burnett-Hartman A; Chubak J; Ghai NR; McLerran D; Breen N; Conant EF; Geller BM; Green BB; Klabunde CN; Inrig S; Skinner CS; Quinn VP; Haas JS; Schnall M; Rutter CM; Barlow WE; Corley DA; Armstrong K; Doubeni CA; Am J Prev Med; 2016 Oct; 51(4):507-12. PubMed ID: 27132628 [TBL] [Abstract][Full Text] [Related]
7. Association of time intervals in cancer screenings and older participants' characteristics, in a nationally representative sample. Razavi M; Bergerot CD; Philip EJ; Dale W J Geriatr Oncol; 2023 Jan; 14(1):101392. PubMed ID: 36344421 [TBL] [Abstract][Full Text] [Related]
8. Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. Weber MF; Banks E; Smith DP; O'Connell D; Sitas F BMC Public Health; 2009 May; 9():144. PubMed ID: 19442312 [TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake. Todorov K; Wilson C; Sharplin G; Corsini N Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632 [TBL] [Abstract][Full Text] [Related]
10. Implications of false-positive results for future cancer screenings. Taksler GB; Keating NL; Rothberg MB Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered? Paul CL; Carey ML; Russell G; D'Este C; Sanson-Fisher RW; Zwar N Health Promot J Austr; 2015 Apr; 26(1):39-44. PubMed ID: 25818504 [TBL] [Abstract][Full Text] [Related]
12. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey. Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613 [TBL] [Abstract][Full Text] [Related]
13. Cancer screening in Queensland men. Carrière P; Baade P; Newman B; Aitken J; Janda M Med J Aust; 2007 Apr; 186(8):404-7. PubMed ID: 17437394 [TBL] [Abstract][Full Text] [Related]
14. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. Ruffin MT; Gorenflo DW; Woodman B J Am Board Fam Pract; 2000; 13(1):1-10. PubMed ID: 10682879 [TBL] [Abstract][Full Text] [Related]
15. Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Cockburn J; Paul C; Tzelepis F; McElduff P; Byles J Aust N Z J Public Health; 2002; 26(3):236-41. PubMed ID: 12141619 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Schumacher MC; Slattery ML; Lanier AP; Ma KN; Edwards S; Ferucci ED; Tom-Orme L Cancer Causes Control; 2008 Sep; 19(7):725-37. PubMed ID: 18307048 [TBL] [Abstract][Full Text] [Related]
18. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey. Breslau ES; Jeffery DD; Davis WW; Moser RP; McNeel TS; Hawley S J Cancer Surviv; 2010 Mar; 4(1):1-14. PubMed ID: 19882379 [TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116 [TBL] [Abstract][Full Text] [Related]
20. Predictors of non-attendance from BreastScreen NSW in women who report current mammography screening. Taylor R; Ivanov O; Page A; Brotherton J; Achat H; Close G Aust N Z J Public Health; 2003 Dec; 27(6):581-7. PubMed ID: 14723404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]